alexa Antihiperglycemic Effect Of 5-HT2 Receptor Stimulation Induced By A Serotonin Analogue
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Enrique Hong Chong
ScientificTracks Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.026
The role of 5-Hydroxytryptamine in the regulation of glycemia has been a controversial item for some time, however, there are recent findings suggesting that 5-HT1A receptor stimulation increases the glycemia, while 5-HT2 receptors do the opposite. Therefore, we decided to investigate the effect of indorenate, a central antihypertensive agent exerting this action by 5-HT1A central receptor stimulation, but also possessing a 5-HT2 peripheral receptor stimulation. Since less than 1 % of the oral administered dose penetrates into the CNS, most of the compound could stimulate the 5-HT2 peripheral receptors leading to an antihyperglycemic effect. The oral dose of glucose (2g/kg) to fasted Wistar rats was followed by a hyperglycemia that was maximal one hr later, this effect was suppressed by the previous administration of an oral dose of 10 mg/kg of indorenate, however, metformin at an oral dose of 300 mg/kg only produce a slight, but significant decrease in hyperglycemia. Pelanserin, a 5-HT2 antagonist, blocked the effect of indorenate, but WAY 100635, a 5HT-1A agonist, did not. Indorenate also increase the glucose velocity needed to maintain blood glucose levels constant in an euglycemic insulin clamp in anesthetized Wistar rats. The present data suggest that indorenate may have a potential therapeutic usefulness in both, metabolic syndrome and in diabetic type2.
Enrique Hong chong obtained his M.D. in 1960 at UNAM and his PhD at Cinvestav in 1984, both are located in Mexico City. He worked at the Miles Institute for Experimental Therapeutics in Mexico City and then became member of the Faculty of Cinvestav, where he was the Head of the Pharmacology and Toxicology Department, and he is now Professor at the Pharmacobiology Department at Cinvestav. He has published more than 130 papers in journals with impact factor and have more than 1000 bibliographical citations to his publications.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version